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Abstract—This paper investigates the effect of conductivity
weighting on microwave images obtained through a dedicated
imaging device. MammoWave is a microwave imaging device for
detection of breast lesions, operating using only two azimuthally
rotating antennas without the use of matching liquids. For each
breast, a set of conductivity weighted images are generated
through modifying our algorithm based on Huygens principle,
producing intensity maps representing the homogeneity of tissues’
dielectric properties. Subsequently, we introduce several imaging
parameters (i.e. features) to quantify the non-homogenous behav-
ior of the image. Through empirical investigation on 103 breasts,
we can verify that a selection of these features could allow dis-
tinction between breasts with radiological findings (WF), i.e. with
benign or malign lesions, and breasts with no radiological findings
(NF). Statistical significance was set at p<0.05. We obtained single
features Area Under the receiver operating characteristic Curves
(AUCs) spanning from 0.65 to 0.68. Significantly, we achieve
AUCs of up to 0.77 when considering dense breasts only, which
tend to cause detection limitations in mammography exams.
Index Terms—Huygens principle, Microwave imaging, Breast
cancer detection.
I. INTRODUCTION
Mammography has long been established as the gold stan-
dard technology for breast screening to reduce breast cancer
mortality [1-3]. However, it comes with drawbacks and safety
concerns, including the use of ionizing radiation, breast com-
pression and performance restrictions due to x-rays’ intrinsic
nature. Significantly, breast density is a restrictive property that
can prevent breast cancer detection in mammograms of women
with radiographically dense breasts [4, 5]. In general, women
are eligible for biannual screening after the age of 49 in order
to minimize the impact of ionizing radiation. However, recent
studies estimate that breast cancer is diagnosed in 6.6% of
women below the age of 40 [4], and an average of 20% of
breast cancer cases in Europe occur in females younger than
50 years old [6].
Many efforts are underway to develop non-ionizing tech-
nologies which could enable screening without age or follow-
up examination interval restrictions. Among these, microwave
imaging has appeared as a promising technology for breast
lesions detection [7]. Microwave imaging methods aim to
discriminate between healthy tissues and tissues with lesions
by exploiting their contrast in dielectric properties, i.e. permit-
tivity and conductivity, within microwave frequencies. A high
contrast (up to 5) has been reported [7] between healthy breast
tissue and malignant tissue, while newer studies confirm a high
contrast only between malignant and fatty breast tissues, and
less contrast between malignant and healthy fibro glandular
tissues [8, 9].
Microwave imaging techniques may be separated into
two main groups: microwave tomography and ultra-wideband
(UWB) radar methods [10]. Microwave tomography is based
on inverse scattering algorithms that create maps of permittiv-
ity and conductivity; however, inverse scattering approaches
could suffer from mathematical instability, which may not
converge to a meaningful solution. UWB radar methods in-
stead perform a linear reconstruction of the image, which is
a scattering map in arbitrary units. A number of microwave
imaging prototypes with varying hardware and imaging algo-
rithms have been constructed and reached clinical level testing
[11].
As one of the few clinically ready products, MammoWave
operates with only two azimuthally rotating antennas without
using any matching liquids. MammoWave has an innovative
frequency domain imaging algorithm, based on Huygens Prin-
ciple (HP) [12]. The device has previously been presented,
tested and clinically validated [13-15]. The apparatus produces
images in the form of intensity maps, representing the homo-
geneity of tissues’ dielectric properties. In this paper, for each
breast we generate a set of conductivity weighted microwave
images. Next, several image features are calculated to quantify
and measure the non-homogenous behaviour of the image.
We show that an appropriate selection of these features could
allow distinction between breasts with radiological findings
(WF), and breasts with no radiological findings (NF). We
have empirically verified the procedure on 103 breasts, each
one with the correspondent radiologist review output obtained
using MRI and/or mammography and/or echography.
The outline of this paper is as follows. Section II describes
the apparatus and the imaging algorithm based on HP. Feature
extraction and feature selection procedures are also explained
in this section. Results are presented and discussed in section
III, while section IV concludes the work and highlights the
future work.
II. MATERIALS AND METHODS
A. Microwave apparatus and imaging algorithm
The MammoWave system (fig. 1(a)), consists of an alu-
minum cylindrical hub containing two antennas, one trans-
mitting (tx) and one receiving antenna (rx), which operate
from 1 to 9 GHz. The hub is internally covered by microwave
absorbers, and is equipped with a hole with a cup, allowing
the insertion of the patient’s breast, with the patient lying in
a prone position (fig. 1(b)). The antennas are installed at the
same height, in free space and rotate around the azimuth col-
lecting the microwave signals from different angular positions
[13]. The tx and rx are connected to a 2-port VNA (Cobalt
C1209, Copper Mountain) which operates up to 9 GHz.
Measurements were performed recording the complex S21
in a multi-bistatic fashion, such that for each transmitting
position txm the receiving antenna is moved to measure the
received signal every 4.5◦, resulting in 80 receiving points
rxnp. A total of 10 transmitting positions have been used
in all measurements, displaced in 5 sections centered at 0◦,
72◦, 144◦, 216◦, and 288◦. Fig. 1(c) illustrates the set-up
configuration. In each section the transmitting positions may
be displaced by 9◦. For each tx and rx position, the complex
S21 is collected from 1 to 9 GHz, with 5 MHz sampling.
Assuming that rx can be rotated to measure the received
signal at the points rxnp ≡ (a0,φnp)≡−→ρ np displaced along a
circular surface having radius a0, the received signals can be
expressed as S21m,pn (a0,φn; txm,p; f ), where n=1,2,. . . ,80, and
m=1,2. . . ,5 indicate the receiving points and the transmitting
sections, respectively, p=1,2 and p′=1,2 indicate the position
inside each transmitting section, and f is the frequency. The
received signals are then processed through HP to calculate
the field inside the cylinder, which is then used to generate an
image. To remove the artefacts [16], we employ the subtraction
between S21 obtained using two measurements belonging to
the doublet of the same section:












where (ρ,φ) ≡ −→ρ is the observation point, and ∆s is the
spatial sampling. Wave number is indicated by k1, and G
represents the Green’s function. The reconstructed internal
field has been indicated by the string “rcstr” while the string
HP indicates that Huygens based procedure will be employed
in (1). If the conductivity of the media is not equal to zero,
(a) (b)
(c)
Fig. 1. The MammoWave system (a). The hub is equipped with a hole with
a cup, allowing the insertion of the patient’s breast in a prone position (b).
The antennas are installed at the same height, in free space and rotate around
the azimuth to collect the signals from different angular positions (c).
(1) compensates the attenuation experienced when going into
the media. Assuming we use NF frequencies fi in the band B,
the intensity of the image I can be obtained using (2) through













|ErcstrHP,2D(ρ,φ; txm,p− txm,p′ ; fi)|2 (2)
B. In-vivo validation
MammoWave’s in-vivo validation on volunteers in Peru-
gia and Foligno Hospitals was approved in 2015 by the
Ethical Committee of Umbria, Italy (N. 6845/15/AV/DM
of 14/10/2015, N. 10352/17/NCAV of 16/03/2017, N
13203/18/NCAV of 17/04/2018), for a feasibility study on
detection of breast lesions with the aim of quantifying its
potential for use in medical technology screening. The inclu-
sion criteria allowed female volunteers above 18 years old
with intact breast skin and with a radiologist study output
obtained through conventional exams (mammography and/or
ultrasound and/or MRI) within the last month. All protocols
and procedures were in accordance with both institutional
and national ethical standards in research, and with World
Medical Association Declaration of Helsinki (1964) and its
later amendments or analogous ethical standards. Prior to the
trial, all participants have been requested to read and sign both
the informative sheet and informed consent form.
The results obtained using the data from 103 breasts are
presented here. Each breast has its own correspondent output
of the radiologist study review, for use as gold standard for
classification of the breasts into two categories: those with no
radiological finding (NF), and those with radiological findings
(WF). Moreover, where possible the breast type has been
classified according to its density, following the scale defined
by the American College of Radiology (ACR) ranked from
ACR1 (extremely fatty breast) to ACR4 (extremely heteroge-
neous fibroglandular breast) [16]. Specifically, we will denote
ACR3 and ACR4 breasts as dense. The lesion type includes
fibroadenoma, carcinoma, nodule, microcalcifications, cyst and
other lesions [17-19].
After agreeing to participate, the subject is assisted by
the clinical study coordinator; she positions her breast in the
cup, which is appropriately integrated in a bed as shown in
fig. 1(b). Three biocompatible cups made of polylactic acid
[20] having varying sizes are available, and the clinical study
coordinator chooses the one that better fits the subject’s breast.
The thickness of the cup is only 1 mm, and does not impact the
imaging results [14]. It should be emphasized that no matching
liquid is used in the apparatus, and no breast compression has
to be applied during acquisition.
All microwave images have been obtained in a cylindrical
grid with a radius of 7 cm (rotation radius of rx), a radial
sampling of 1 mm and an azimuthal sampling of 3◦. The
images have been obtained using free space dielectric constant
in (1), due to the position of rx in air. For each breast
we investigated the variation of conductivity (σ) from 0 to
0.9 S/m (0.1 S/m sampling). When applying (1). We will
refer to such microwave images as conductivity weighted
microwave images, denoted as MIσ. Images obtained here are
intensity maps, given in linear arbitrary units, representing the
homogeneity of tissues’ dielectric properties. To allow inter
and intra-subject comparison, all images are normalized to
unitary average of the intensity.
C. Feature Extraction
To quantify the non-homogenous behaviour of the mi-
crowave images, we introduce the following features:
• MIN = Minimum image intensity;
• MAX = Maximum image intensity;
• MEA = Mean value of image intensity;
• MED = Median value of image intensity;
• VAR = Variance of image intensity;
• MAD0 = Mean absolute deviation of image intensity;
• MAD1 = Median absolute deviation of image intensity;
• KUR = Kurtosis of the image;
• SKE = Skewness of the image;
• M2AVG = (MAX) / (MEA);
• ROS1 = (MAX-MIN) / (MEA-MIN);
• ROS2 = (MAX-MIN) / (MED-MIN);
• ENT = Entropy of the image.
For each conductivity weighted image, these are calculated





with the subscript “i”. Additionally, for each conductivity
weighted image, all features excluding KUR, SKE, ROS1,
ROS2 are calculated on the peak region (a region which is cen-
tered in the maximum of the image and it extends to MAX/2),
denoted with the subscript “p”; and on its complementary,
denoted with the subscript “c”. The ratios between features
calculated on the peak region and on its complementary
are considered as added features, and are highlighted with
subscript “r”.
Next, for each feature, using the gold standard output of the
radiologist study review (NF or WF category), we calculate:
the mean and standard deviation for both NF and WF breasts.
In addition, for each feature, using the radiologist study review
output, Welch’s t-test (i.e. a two-sample two-tailed unpooled
variances t-test) with α= 0.05 has been performed. Statistical
significance was set at p<0.05. We also numerically evaluated
the receiver operating characteristic (ROC): specifically, we
evaluated True Positive (TP) and False Negative (FN) rates
for each feature of each conductivity weighted image. In more
details, since TP rate and FN rate depend on the classifier
threshold, i.e. the decision offset, we empirically calculated
ROC curves by adjusting the decision offset and calculating
TP and FN for all possible decision offsets. Thus, the area
under the curve (AUC) is determined.
D. Feature Selection and Calculations
With the aim of empirically verifying if an appropriate
selection of microwave image features may allow discrimi-
nating between NF and WF breasts, the following steps are
performed for each conductivity weighted image: i) for the
ROC of each feature, the TP rate obtained for True Negative
(TN) rate TN=0.55, i.e. TP|TN=0.55 is calculated, and the
corresponding decision offset is annotated. ii) we order the
feature with decreasing TP|TN=0.55 and we select the first four
after checking that p<0.05 is verified.
III. RESULTS AND DISCUSSIONS
According to the radiologist study review, a total number
of 52 NF (19 dense) and 51 WF (22 dense) breasts were ana-
lyzed, which included nodules, cyst, carcinoma, fibroadenoma,
microcalcifications.
Four selected features corresponding to three different con-
ductivity weighed images are listed in Table 1. For each
feature, we indicate: the mean and standard deviation for
the NF breasts, the mean and standard deviation for the WF
breasts, the decision offset corresponding to TN=0.55, the
AUC for all breasts and AUC for dense breasts only. ROC
curves (empirically calculated) are shown in Fig. 2.
Two breasts are shown here in more details as test cases,
each one with three of the selected conductivity weighed
microwave images (for σ equal to 0.3 S/m, 0.6 S/m and 0.8
S/m, respectively). Microwave images, normalized to unitary
average of the intensity, are given here as 2D images in the
azimuthal (coronal) plane and are divided into four quadrants
corresponding to breast Upper-Outer (UO) quadrant; Upper-
Inner (UI) quadrant; Lower-Outer (LO) quadrant; Lower-Inner
(LI) quadrant. Moreover, 1D intensity projection on x and
y is displayed in the inserts. X and y axes are in meters
TABLE I













VARp 0.152±0.070 0.201±0.085 0.144 0.68 0.71
MAD0p 0.308±0.073 0.353±0.077 0.305 0.66 0.69
VARr 1.115±0.604 1.397±0.612 1.060 0.67 0.71
M2AVGi 2.143±0.320 2.317±0.350 2.124 0.66 0.73
σ=0.6
VARp 0.335±0.108 0.416±0.147 0.311 0.68 0.76
M2AVGi 2.499±0.386 2.753±0.447 2.479 0.68 0.75
MAXp 2.499±0.386 2.753±0.447 2.479 0.66 0.75
ROS1i 2.548±0.392 2.805±0.453 2.530 0.67 0.69
σ=0.8
M2AVGi 2.700±0.420 2.981±0.491 2.654 0.67 0.77
MAXp 2.700±0.420 2.981±0.491 2.654 0.67 0.77
ROS1i 2.731±0.423 3.013±0.494 2.674 0.67 0.76
ROS2i 2.908±0.708 3.346±0.857 2.773 0.66 0.71
(a) (b)
(c)
Fig. 2. ROC curves of the selected features for σ values equal to 0.3 (a), 0.6
(b), and 0.8 (c).
while intensity is in arbitrary units. For each test case the
output and main findings of the radiologist study review, with
the correspondent conventional images, is also given. Fig. 3




Fig. 3. NF heterogeneously dense (ACR 3) breast; (a)-(c) represent the
microwave images (in arbitrary units) when employing σ values 0.3, 0.6, and
0.8 S/m, respectively. Microwave images (x and y axes are in meters) show a
homogeneous behavior. The radiologist study review has been obtained with
mammography images (d).
MammoWave does not use any patient-specific estimation,
which means that breast images are generated without any
prior knowledge of patient-specific breast dielectric properties.
In more details, the images have been obtained using free
space dielectric constant in (1). Concerning the conductivity,
for each breast we varied the conductivity from 0 to 0.9 S/m (in
agreement with the breast conductivity average values reported
in [10]). Here we presented microwaves images corresponding
to 3 sample conductivity values within this range.
From visual inspection of microwave images, it can be
pointed out that microwave images of WF breasts have a
more non-homogenous behaviour with respect to NF breast.
This confirms what was previously highlighted in [13, 14],
using phantom measurements. Interestingly, small microcal-
cifications (1.6 mm) also lead to non-homogenous behaviour
which can be visually appreciated.
With the aim of discriminating between WF and NF breasts,
some dedicated features have been introduced and selected.
Such features allow a quantification of the non-homogeneity
of the microwave images: some of them describe the entire
image [13, 14], while others describe the peak region [21].
AUC of selected features span from 0.65 to 0.68. Significantly,
when calculating the AUCs of the selected features for dense
breasts only, we see an increase of up to 0.77.
IV. CONCLUSIONS AND FUTURE WORK
This paper presented an investigation on the effect of
conductivity weighting on detection capabilities of a mi-
crowave imaging prototype for breast lesion detection. Our
(a) (b)
(c) (d)
Fig. 4. WF heterogeneously dense (ACR 3) breast; (a)-(c) represent the
microwave images (in arbitrary units) when employing σ values 0.3, 0.6,
and 0.8 S/m, respectively. All microwave images (x and y axes are in meters)
show a non-homogeneous behavior, with a main peak indicated by the red
arrows. The radiologist study review has been obtained with mammography
images (d), giving as output the presence of Microcalcifications of 1.6 mm.
results verify that a selection of features obtained from a
range of conductivity weighted microwave images may allow
discrimination between NF and WF breasts, while passing the
Welch’s t-test. Next steps will be focused on verifying if an
appropriate combination and use of microwave image features
may enhance performance accuracy compared with single
feature. Further work on MammoWave, which has recently
received CE Mark is ongoing and larger clinical trials are
planned with the aim of improving clinical evidence on the
use of microwave imaging in the breast screening pathway.
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